An Essential Role for Peptidergic Signalling in the Control of Circadian Rhythms in the Suprachiasmatic Nuclei

Journal of Neuroendocrinology - Tập 15 Số 4 - Trang 335-338 - 2003
Anthony J. Harmar1
1Division of Neuroscience, University of Edinburgh, 1 George Square, Edinburgh EH8 9JZ, Scotland, UK.

Tóm tắt

Abstract

Two structurally related neuropeptides, pituitary adenylate cyclase‐activating polypeptide (PACAP), colocalized with glutamate in neurones of the retinohypothalamic tract, and vasoactive intestinal peptide (VIP), present in light‐responsive cells of the suprachiasmatic nuclei (SCN), appear to play distinct and important roles in the control of mammalian circadian rhythms. Mice deficient in the PACAP‐selective PAC1 receptor exhibit altered responsiveness of the SCN clock to light‐induced phase‐shifts, but display robust circadian patterns of wheel‐running behaviour. By contrast, our studies of mice lacking the VPAC2 receptor, which responds to both PACAP and VIP, indicate that this receptor plays a critical role in rhythm generation in the SCN. The predominant factor determining wheel‐running activity in VPAC2 receptor null (Vipr2–/–) mice is ‘masking’ by light. Mutant animals re‐entrain immediately to advances or delays in the light/dark cycle and do not exhibit robust circadian rhythms of behaviour when in constant darkness. The mice do not exhibit circadian expression of core clock genes (mPer1, mPer2, mCry1), or of the clock‐controlled gene arginine vasopressin (AVP), in the SCN. We propose that VIP signalling between SCN neurones provides a paracrine reinforcing signal that is essential for sustained rhythm generation. The presence of VIP signalling in the SCN may explain why SCN neurones are capable of generating long‐lasting self‐sustained oscillations, whereas rhythmic clock gene expression in other tissues is dependent on periodic reinforcement by neural or hormonal signals.

Từ khóa


Tài liệu tham khảo

10.1186/gb-2001-2-12-reviews3013

Harmar AJ, 1998, International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase‐activating polypeptide, Pharmacol Rev, 50, 265

10.1523/JNEUROSCI.22-01-j0002.2002

10.1002/(SICI)1096-9861(20000306)418:2<147::AID-CNE2>3.0.CO;2-#

10.1016/S0301-0082(96)00032-9

10.1523/JNEUROSCI.19-15-06637.1999

Von Gall C, 1998, CREB in the mouse SCN: a molecular interface coding the phase‐adjusting stimuli light, glutamate, PACAP, and melatonin for clockwork access, J Neurosci, 18, 10389, 10.1523/JNEUROSCI.18-24-10389.1998

10.1523/JNEUROSCI.17-07-02637.1997

10.1016/S0304-3940(01)01796-7

Kopp MD, 1999, Pituitary adenylate cyclase‐activating polypeptide and melatonin in the suprachiasmatic nucleus: effects on the calcium signal transduction cascade, J Neurosci, 19, 206, 10.1523/JNEUROSCI.19-01-00206.1999

10.1523/JNEUROSCI.21-13-04883.2001

10.1016/S0306-4522(01)00479-1

10.1016/S0006-8993(98)01044-0

10.1016/S0304-3940(97)00869-0

10.1046/j.1471-4159.2001.00553.x

10.1002/(SICI)1096-9861(19960812)372:1<1::AID-CNE1>3.0.CO;2-7

10.1523/JNEUROSCI.17-10-03920.1997

10.1016/S0006-8993(01)02890-6

10.1016/S0169-328X(98)00289-7

10.1016/0014-5793(93)81668-P

10.1016/0306-4522(95)00048-N

10.1210/en.135.6.2662

10.1046/j.1365-2826.2002.00826.x

10.1046/j.0953-816x.2000.01437.x

10.1523/JNEUROSCI.15-08-05612.1995

10.1016/S0006-8993(00)02724-4

10.1073/pnas.97.21.11575

10.1016/S0092-8674(02)00736-5

10.1101/SQB.1960.025.01.004

10.1124/mol.61.1.26

10.1126/science.1067716